ALLR Allarity Therapeutics Inc

Price (delayed)

$1.04

Market cap

$16.55M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.78

Enterprise value

$11.85M

?
Relative Growth: Rel. Growth: 1
Relative Strength: Rel. Strength: 21
Relative Valuation: Rel. Valuation: 5
Relative Profitability: Rel. Profitability: 34
Highlights
Allarity Therapeutics's net income has increased by 49% YoY but it has decreased by 10% QoQ
Allarity Therapeutics's EPS has shrunk by 150% YoY and by 8% QoQ
ALLR's equity has plunged by 71% YoY and by 49% from the previous quarter

Key stats

What are the main financial stats of ALLR

ALLR stock price

How has the Allarity Therapeutics stock price performed over time
Intraday
-6.31%
1 week
-9.96%
1 month
-26.76%
1 year
-35%
YTD
-3.7%
QTD
-19.38%

Financial performance

How have Allarity Therapeutics's revenue and profit performed over time
Revenue
$345,000
Gross profit
$345,000
Operating income
-$10.8M
Net income
-$12.33M
Gross margin
100%
Net margin
-3,575.1%
ALLR's operating income has surged by 60% year-on-year and by 12% since the previous quarter
Allarity Therapeutics's net income has increased by 49% YoY but it has decreased by 10% QoQ
Allarity Therapeutics's operating margin has increased by 12% from the previous quarter
The company's net margin fell by 10% QoQ

Price vs fundamentals

How does ALLR's price correlate with its fundamentals

Growth

What is Allarity Therapeutics's growth rate over time

Valuation

What is Allarity Therapeutics stock price valuation
P/E
N/A
P/B
4.68
P/S
47.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
34.35
Allarity Therapeutics's EPS has shrunk by 150% YoY and by 8% QoQ
ALLR's equity has plunged by 71% YoY and by 49% from the previous quarter
ALLR's P/B is 66% above its last 4 quarters average of 3.0

Efficiency

How efficient is Allarity Therapeutics business performance
Allarity Therapeutics's ROA has soared by 56% YoY
ALLR's ROE is down by 39% QoQ but it is up by 14% YoY
Allarity Therapeutics's return on sales has decreased by 3.5% QoQ

Dividends

What is ALLR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ALLR.

Financial health

How did Allarity Therapeutics financials performed over time
ALLR's total assets is 12% more than its total liabilities
Allarity Therapeutics's quick ratio has shrunk by 52% YoY and by 11% QoQ
The current ratio has dropped by 52% year-on-year and by 10% since the previous quarter
ALLR's debt to equity has surged by 103% since the previous quarter
ALLR's equity has plunged by 71% YoY and by 49% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.